EU Inches Closer to New Pharma Legislation Amid Competitiveness Drive
Wedoany.com Report-Dec.13, European Union legislators have reached a provisional agreement on a revi...
Novartis and UK-Based Relation Forge R&D Deal Worth up to $1.7bn
Wedoany.com Report-Dec.12, Novartis, the Swiss pharmaceutical company, has entered a strategic colla...
Health Canada Approves Biogen’s Zurzuvae for PPD Treatment
Wedoany.com Report-Dec.11, Biogen Canada Inc. has received a Notice of Compliance from Health Canada...
Eli Lilly Picks Alabama as Home to $6BN Orforglipron Manufacturing Facility
Wedoany.com Report-Dec.11, Eli Lilly and Company has selected Huntsville, Alabama, as the site for i...
Pfizer to Cut Over 200 Jobs in Switzerland to Reduce Costs
Wedoany.com Report-Dec.11, Pfizer plans to reduce its workforce in Switzerland by more than 200 posi...
Roche Breast Cancer Pill Cuts Risk of Disease Recurrence by 30% in Trial
Wedoany.com Report-Dec.11, Roche announced on Wednesday that its investigational oral drug giredestr...
Daehwa’s Oral Paclitaxel Liporaxel Added to China’s National Reimbursement List
Wedoany.com Report-Dec.8, Daehwa Pharmaceutical announced on Monday that its oral paclitaxel antican...
Johnson & Johnson Wins EU Approval for New GMG Treatment
Wedoany.com Report-Dec.5, The European Commission has granted marketing authorisation for nipocalima...
J&J gets EU approval for Imaavy in gMG News
Wedoany.com Report-Dec.3, Johnson & Johnson's Imaavy (nipocalimab) has received European Commis...
US Announces Zero Tariff Pharmaceutical Deal With Britain
Wedoany.com Report-Dec.2, The United States and the United Kingdom revealed an agreement on Monday t...